1. Home
  2. CXW vs OCUL Comparison

CXW vs OCUL Comparison

Compare CXW & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CoreCivic Inc.

CXW

CoreCivic Inc.

HOLD

Current Price

$17.45

Market Cap

2.1B

Sector

Real Estate

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$9.61

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXW
OCUL
Founded
1983
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2001
2014

Fundamental Metrics

Financial Performance
Metric
CXW
OCUL
Price
$17.45
$9.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$34.00
$22.33
AVG Volume (30 Days)
1.0M
7.1M
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
74.19
N/A
EPS
1.08
N/A
Revenue
$2,211,182,000.00
$1,990,000.00
Revenue This Year
$17.00
$10.00
Revenue Next Year
$9.55
$102.68
P/E Ratio
$15.90
N/A
Revenue Growth
12.72
3.48
52 Week Low
$15.74
$5.79
52 Week High
$23.54
$16.44

Technical Indicators

Market Signals
Indicator
CXW
OCUL
Relative Strength Index (RSI) 42.60 53.09
Support Level $16.04 $8.36
Resistance Level $19.61 $12.63
Average True Range (ATR) 0.95 0.57
MACD -0.14 0.24
Stochastic Oscillator 43.40 95.63

Price Performance

Historical Comparison
CXW
OCUL

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: